Biodistribution and histopathology studies of amphotericin B sodium deoxycholate sulfate formulation following intratracheal instillation in rat models
- PMID: 31368043
- DOI: 10.1007/s13346-019-00662-x
Biodistribution and histopathology studies of amphotericin B sodium deoxycholate sulfate formulation following intratracheal instillation in rat models
Abstract
Aerosol inhalation of amphotericin B (AmB) can be a clinically compliant way to administer the drug directly to the pulmonary route for treatment as well as prophylaxis of invasive pulmonary aspergillosis (IPA). We report aerosol formulation of AmB using sodium deoxycholate sulfate (SDCS), a lipid carrier synthesized in-house using natural precursor deoxycholic acid. In vitro toxicity was determined by MTT assay. Biodistribution and histopathology in rats were evaluated in targeted organs including the lungs, kidneys, spleen, and liver. No toxicity was observed when lung and kidney cells treated with AmB-SDCS formulations up to 8 μg/mL and minimal toxicity at higher concentration 16 μg/mL, while the Fungizone®-like formulation induced toxicity to lung and kidney cells with viability decreasing from 86 to 41% and 100 to 49%, respectively, when compared with an equivalent concentration of AmB-SDCS. Renal and hepatic markers were raised for Fungizone®-like formulation-treated rats but not for AmB-SDCS formulations following 7 days of regular dosing by intratracheal instillation. AmB concentrations were highest in the lungs (5.4-8.3 μg/g) which were well above minimum inhibitory concentration (MIC) of all Aspergillus species. Plasma concentration was also above MIC (> 2 μg/mL) for all AmB-SDCS formulations in comparison with Fungizone®-like formulation. No evidence of abnormal histopathology was observed in the lungs, liver, spleen, and kidneys for all AmB-SDCS formulations but was observed for the group treated with Fungizone®-like formulation. It is concluded that AmB-SDCS formulations can be efficiently administered via intratracheal instillation with no evidence of toxicity and may find great value in the treatment as well as prophylaxis of IPA through inhalation route.
Keywords: Amphotericin B; Biodistribution; Histopathology; Intratracheal instillation; Sodium deoxycholate sulfate.
Similar articles
-
Bioactivity, Safety, and Efficacy of Amphotericin B Nanomicellar Aerosols Using Sodium Deoxycholate Sulfate as the Lipid Carrier.AAPS PharmSciTech. 2018 Jul;19(5):2077-2086. doi: 10.1208/s12249-018-1013-4. Epub 2018 Apr 24. AAPS PharmSciTech. 2018. PMID: 29691753
-
Synthesis and evaluation of sodium deoxycholate sulfate as a lipid drug carrier to enhance the solubility, stability and safety of an amphotericin B inhalation formulation.Int J Pharm. 2014 Aug 25;471(1-2):430-8. doi: 10.1016/j.ijpharm.2014.05.066. Epub 2014 Jun 4. Int J Pharm. 2014. PMID: 24907597
-
Physiologically based pharmacokinetic model of amphotericin B disposition in rats following administration of deoxycholate formulation (Fungizone®): pooled analysis of published data.AAPS J. 2011 Jun;13(2):255-64. doi: 10.1208/s12248-011-9267-8. Epub 2011 Mar 23. AAPS J. 2011. PMID: 21431453 Free PMC article.
-
Super aggregated form of Amphotericin B: a novel way to increase its therapeutic index.Curr Pharm Des. 2016;22(7):792-803. doi: 10.2174/1381612822666151209151719. Curr Pharm Des. 2016. PMID: 26648472 Review.
-
Continuous infusion of amphotericin B deoxycholate: an innovative, low-cost strategy in antifungal treatment.Mycoses. 2011 Mar;54(2):91-8. doi: 10.1111/j.1439-0507.2009.01805.x. Mycoses. 2011. PMID: 19878457 Review.
Cited by
-
In vivo evaluation of nephrotoxicity and neurotoxicity of colistin formulated with sodium deoxycholate sulfate in a mice model.Naunyn Schmiedebergs Arch Pharmacol. 2023 Nov;396(11):3243-3252. doi: 10.1007/s00210-023-02531-4. Epub 2023 May 30. Naunyn Schmiedebergs Arch Pharmacol. 2023. PMID: 37249614
-
Lung and general health effects of Toll-like receptor-4 (TLR4)-interacting SPA4 peptide.BMC Pulm Med. 2020 Jun 23;20(1):179. doi: 10.1186/s12890-020-01187-7. BMC Pulm Med. 2020. PMID: 32576172 Free PMC article.
-
Lipid Systems for the Delivery of Amphotericin B in Antifungal Therapy.Pharmaceutics. 2020 Jan 1;12(1):29. doi: 10.3390/pharmaceutics12010029. Pharmaceutics. 2020. PMID: 31906268 Free PMC article. Review.
-
Inhaled Antifungal Agents for Treatment and Prophylaxis of Bronchopulmonary Invasive Mold Infections.Pharmaceutics. 2022 Mar 14;14(3):641. doi: 10.3390/pharmaceutics14030641. Pharmaceutics. 2022. PMID: 35336015 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources